Evolus to Participate in Three Upcoming Investor Conferences
NEWPORT BEACH, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in three upcoming investor conferences in New York, NY.
| Event: | Jefferies 2019 Healthcare Conference |
| Format: | Fireside Chat & 1x1 Meetings |
| Date: | Wednesday, June 5, 2019 |
| Time: | 4:30pm ET |
| Location: | Grand Hyatt New York |
| Event: | JMP Securities Life Sciences Conference |
| Format: | Fireside Chat & 1x1 Meetings |
| Date: | Wednesday, June 19, 2019 |
| Time: | 3:30pm ET |
| Location: | The St. Regis New York |
| Event: | BMO 2019 Prescriptions for Success Healthcare Conference |
| Format: | Fireside Chat and 1x1 Meetings |
| Date: | Tuesday, June 25, 2019 |
| Time: | 2:20pm ET |
| Location: | Mandarin Oriental New York |
Audio webcasts of Evolus’ fireside chats will be available on the investor relations section of Evolus’ website at . Replays of the webcasts will be available for 90 days after the date of the presentation.
About Evolus, Inc.
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau™ (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau™ is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: .
Jeuveau™ is a trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Evolus, Inc. Contacts:
Investors Contacts:
Ashwin Agarwal, Evolus, Inc.
Vice President, Finance, Investor Relations & Treasury
Tel:
Email:
Tram Bui & Kaitlyn Brosco, The Ruth Group
Tel:
Email:
Media Contacts:
Crystal Muilenburg, Evolus, Inc.
Vice President, Corporate Communications & Public Relations
Tel:
Email:
